Clinical trials
Carcinoma, Ovarian Epithelial trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 5 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 18 |
| Active, not recruiting | 9 |
| Recruiting | 6 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 14 |
| NCIC Clinical Trials Group | 6 |
| University Health Network, Toronto | 6 |
| National Cancer Institute (NCI) | 5 |
| AstraZeneca | 4 |
| pharmaand GmbH | 4 |
| AltaRex | 2 |
| Amgen | 2 |
| ImmunoGen, Inc. | 2 |
| ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 76 |
| Ovarian Neoplasms | 48 |
| Fallopian Tube Neoplasms | 39 |
| Neoplasms | 9 |
| Endometrial Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Recurrence | 5 |
| Uterine Cervical Neoplasms | 5 |
| Breast Neoplasms | 4 |
Trials
Showing 76 to 76 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.